CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-28 | Ward Anne Sempowski Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2019-08-26 | DUGAN RICHARD W Director | Option exercise | +15,000 | $14.78 | $222K | 50,770 |
| 2019-08-26 | DUGAN RICHARD W Director | Sale | −15,000 | $14.85 | $223K | 35,770 |
| 2019-08-26 | DUGAN RICHARD W Director | Option exercise · Nonstatutory Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2019-08-19 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award | +30,000 | 30,000 | ||
| 2019-08-19 | Wijkstrom Joakim SVP, Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2019-08-14 | Williams Timothy SVP & General Counsel | Sale | −2,575 | $14.69 | $38K | 57,425 |
| 2019-06-13 | Watkins Thomas Director | Grant or award | +5,000 | 30,000 | ||
| 2019-06-13 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-13 | DUGAN RICHARD W Director | Grant or award | +5,000 | 35,770 | ||
| 2019-06-13 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-13 | COLA MICHAEL F Director | Grant or award | +5,000 | 15,000 | ||
| 2019-06-13 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-13 | Chrousos Phaedra Director | Grant or award | +5,000 | 5,000 | ||
| 2019-06-13 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-05-21 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +79,019 | $12.55 | $992K | 1,284,327 |
| 2019-05-21 | Polymeropoulos Mihael Hristos President and CEO | Sale | −72,872 | $15.34 | $1.1M | 1,211,455 |
| 2019-05-21 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −79,019 | 0 | ||
| 2019-05-20 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +73,608 | $12.55 | $924K | 1,272,726 |
| 2019-05-20 | Polymeropoulos Mihael Hristos President and CEO | Sale | −67,418 | $15.12 | $1.0M | 1,205,308 |
Page 16 of 20 · 387 trades